Well, I sure was wrong on 2.55-2.56 as 2.25 was CY
Post# of 148236
With all that our science has shown to date, we are very under valued and it seems likely that we have significant pressure on the stock price as no one wants Cytodyn to succeed in battling the larger pharma companies.
Shareholders are just going to have to wait until the proof is in the pudding and our pudding is efficacy far better than what the larger pharma companies can produce. It's just plain and simple in this time and space that we have to show the world, a superiority in proof, power, importance, and strength or as I know the word, preponderance of evidence. Proof of concept way beyond what the scientific community can conceptualize is what we have to show, again, plain and simple.
As long as the company, (CYDY), can continue to enroll here and in the UK/EU, when and how quickly they can start, only then can we show our results and that will get us awareness around the globe - GLTA
HCIT